Cell Culture Technology– category –
-
STEMCELL Technologies Launches Human iPSC-Derived Hepatic Organoids, Advancing Liver Research
STEMCELL Technologies Canada Overview STEMCELL Technologies has launched human iPSC-derived hepatic organoid products to advance research into liver development, drug-induced liver injury, hepatotoxicity, and metabolism. These organoids ... -
Laboratories Accelerate Shift to Automated Adherent and Suspension Cell Culture Platforms with CellXpress.ai Supporting Diverse Cell Types
News-Medical.Net UK Overview Laboratories are rapidly transitioning to automated adherent and suspension cell culture platforms like the CellXpress.ai system. This platform supports diverse cell types including 2D adherent, suspension, a... -
Lonza, Samsung Biologics, and Catalent Lead 2026 Biologics CDMO Market, Driven by AI Manufacturing & APAC Expansion
Towards Healthcare Unknown Overview Lonza, Samsung Biologics, and Catalent are identified as key players leading the 2026 biologics CDMO market. Lonza excels in end-to-end multi-modality and scientific innovation, Samsung Biologics in la... -
Immersive Biotech Energy Natural Resources Platform Market Leverages AI and Sensor Networks for Optimization
Digital Journal Canada Overview This article provides an overview of a market research report published by Digital Journal. The Immersive Biotech Energy Natural Resources Platform market utilizes AI-powered machine learning models to int... -
Bioprocessing’s ‘AI’ Demystified: Machine Learning Integrates with Existing Tech, Emphasizing Real-time Data at 2026 Summit
Mewburn Ellis UK Overview Discussions at the 2026 Global Bioprocessing & Biotechnology Summit clarified that 'AI' in bioprocessing refers not to large language models, but to the integration of machine learning into existing modeling... -
CellXpress.ai System Automates Brain Organoid Generation from iPSCs, Boosting Reproducibility and Efficiency for Neuroscience Research
News-Medical.Net UK Overview The CellXpress.ai automated cell culture system has been developed for the automated generation of brain organoids from iPSCs. Integrating liquid handlers, incubators, imagers, and machine learning-assisted i... -
Frederick National Lab Establishes High-Throughput Tumor Organoid Platform Using MIMETAS OrganoPlate for Precision Oncology
Frederick National Laboratory for Cancer Research USA Overview The Frederick National Laboratory for Cancer Research has established an advanced tumor organoid platform for precision oncology, leveraging MIMETAS' perfusion-enabled, high-... -
Distek Launches BIOne Core Cloud Software for Centralized Bioprocess Data Management
Distek, Inc. USA Overview Distek, Inc. has released BIOne Core software, a cloud-hosted historical platform exclusively for its BIOne bioprocess controllers. This SaaS solution centralizes live process trending, automatic data logging, a... -
AGC Biologics Secures CDMO Contract with Teikoku Seiyaku for Recombinant rhMMP-7 Drug Substance, GMP Production at Chiba Plant
AGC Biologics Japan Overview AGC Biologics has signed a CDMO contract with Teikoku Seiyaku Co. for the microbial drug substance manufacturing of recombinant human matrix metalloproteinase-7 (rhMMP-7) 'KTP-001'. Initial cell bank creation... -
Stirred Single-Use Bioreactors Achieve 2000L Commercial Scale; Modular Hybrid Platforms Match 5000L Batch Yields
CDMO World Unknown Overview Stirred single-use bioreactors (SUBs) have proven reliable for commercial biologics manufacturing up to 2000L. A novel 'modular hybrid upstream platform' integrating 500L SUBs with continuous perfusion modules...
